• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Rare Genomics Institute Launches 10 Crowdfunding Campaigns to Help Rare Disease Patients

by HITC Staff 09/15/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Rare Genomics Institute

Rare Genomics Institute (RG) is launching ten separate crowdfunding campaigns to help patients with rare diseases pinpoint the causes of their illnesses. All amounts raised will go towards exome sequencing, which is a cutting-edge method of partial genome sequencing to find the genetic causes of diseases.

This effort is part of Amplify Hope, initiated by RG to determine the most effective crowdfunding programs and measure their effect on scientific education. Amplify Hope is a new RG study funded by the John Templeton Foundation that provides crowdfunding training to rare disease families and tracks the overall reach and scientific impact to help rare disease patients.

“Rare Genomics Institute has helped hundreds of families with rare diseases,” said Jimmy Lin, MD, PhD, MHS, President of the Rare Genomics Institute. “This project encourages the community to join our continuous efforts to help the families who have literally exhausted all other options. By donating and spreading the word about these campaigns, we’ll be able to fund the exome sequencing to uncover the exact cause of their illness.”

Some examples of the campaigns launching today include a beautiful 5 year old girl with an extremely rare and yet still undiagnosed condition that has caused her to have overall developmental delays.

“At five years old, Ria has yet to take her first step, has yet to say her first words or call for Mommy or Daddy,” said her father, Rod Booker. “Ria has severe hypotonia and cannot control her arms and leg movements. She cannot eat solid food and cannot grasp toys to play with them as a typical 5 year old.” Her parents hope exome sequencing will find answers to help Ria.”

Rare Genomics is inviting patients, families, friends, industry partners and everyone to support the Amplify Hope Initiative. Please join us in these campaigns featured on CrowdRise, Indiegogo Life and YouCaring. All money raised above the goal amounts will go to help undiagnosed rare disease children get exome sequencing.

Rare Genomics’ crowdfunding partners on this project include three leading industry pioneers: CrowdRise, Indiegogo Life and YouCaring. Our partners also include two life sciences technology leaders: Ambry Genetics and Baylor Miraca Genetics Laboratories.

For more information about the Amplify Hope, please visit http://amplifyhope.raregenomics.org/

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |